Matrix-assisted laser desorption ionization-time of flight (MALDITOF) mass spectrometry for detection of antibiotic resistance mechanisms: From research to routine diagnosis

Clinical Microbiology Reviews

Volumn 26, Issue 1, 2013, Pages 103-114

  Hrabák, Jaroslav ^a   Chudác ̌ková, Eva ^a   Walková, Radka ^a  

^a CHARLES UNIVERSITY   (Czech Republic)

Author keywords

[No Author keywords available]

Indexed keywords

AMINOGLYCOSIDE; AMPICILLIN; ANTIBIOTIC AGENT; BETA LACTAMASE; CARBAPENEMASE; CEFOTAXIME; CEFOXITIN; CEFTAZIDIME; CHLORAMPHENICOL; CLAVULANIC ACID; CLINDAMYCIN; COLISTIN; DODECYL SULFATE SODIUM; EDETIC ACID; ERTAPENEM; FLORFENICOL; IMIPENEM; MEROPENEM; METALLO BETA LACTAMASE; METHYLTRANSFERASE; PENICILLIN BINDING PROTEIN; PENICILLIN G; PIPERACILLIN; RIBOSOME RNA;

ANTIBIOTIC RESISTANCE; ARTICLE; BACTERIAL CELL WALL; BACTERIAL TRANSMISSION; ENZYME ACTIVITY; HYDROLYSIS; MATRIX ASSISTED LASER DESORPTION IONIZATION TIME OF FLIGHT MASS SPECTROMETRY; METABOLISM; METHICILLIN RESISTANT STAPHYLOCOCCUS AUREUS; NONHUMAN; POLYMERASE CHAIN REACTION; PROTEOMICS; SINGLE NUCLEOTIDE POLYMORPHISM; SPECTROPHOTOMETRY; VANCOMYCIN RESISTANT ENTEROCOCCUS;

ANTI-BACTERIAL AGENTS; BACTERIA; BIOMEDICAL RESEARCH; DRUG RESISTANCE, BACTERIAL; MICROBIAL SENSITIVITY TESTS; SPECTROMETRY, MASS, MATRIX-ASSISTED LASER DESORPTION-IONIZATION;

BACTERIA (MICROORGANISMS);

EID: 84872176158     PISSN: 08938512     EISSN: 10986618     Source Type: Journal    
DOI: 10.1128/CMR.00058-12     Document Type: Article

References (78)

1. Seng P, Rolain J-M, Fournier PE, La Scola B, Drancourt M, Raoult D. 2010. MALDI-TOF-mass spectrometry applications in clinical microbiology. Future Microbiol. 5:1733-1754.
2. Wieser A, Schneider L, Jung J, Schubert S. 2012. MALDI-TOF MS in microbiological diagnostics-identification of microorganisms and beyond. Appl. Microbiol. Biotechnol. 93:965-974.
3. Livermore DM. 2012. Fourteen years in resistance. Int. J. Antimicrob. Agents 39:283-294.
4. Nordmann P, Dortet L, Poirel L. 2012. Carbapenem resistance in Enterobacteriaceae: here is the storm! Trends Mol. Med. 18:263-272.
5. Hrabák J, Niemczyková J, Chudácková E, Fridrichová M, Studentová V, Cervená D, Urbásková P, Zemlicková H. 2011. KPC-2-producing Klebsiella pneumoniae isolated from a Czech patient previously hospitalized in Greece and in vivo selection of colistin resistance. Folia Microbiol. (Praha) 56:361-365.
6. Tzouvelekis LS, Markogiannakis A, Psichogiou M, Tassios PT, Daikos GL. 2012. Carbapenemases in Klebsiella pneumoniae and other Enterobacteriaceae: an evolving crisis of global dimensions. Clin. Microbiol. Rev. 25:682-707.
7. Bush K, Jacoby GA, Medeiros AA. 1995. A functional classification scheme for beta-lactamases and its correlation with molecular structure. Antimicrob. Agents Chemother. 39:1211-1233.
8. Shakil S, Khan R, Zarrilli R, Khan AU. 2008. Aminoglycosides versus bacteria-a description of the action, resistance mechanism, and nosocomial battleground. J. Biomed. Sci. 15:5-14.
9. Smith CA, Baker EN. 2002. Aminoglycoside antibiotic resistance by enzymatic deactivation. Curr. Drug Targets Infect. Disord. 2:143-160.
10. Nikaido H. 2003. Molecular basis of bacterial outer membrane permeability revisited. Microbiol. Mol. Biol. Rev. 67:593-656.
11. Zapun A, Contreras-Martel C, Vernet T. 2008. Penicillin-binding proteins and beta-lactam resistance. FEMS Microbiol. Rev. 32:361-385.
12. Strahilevitz J, Jacoby GA, Hooper DC, Robicsek A. 2009. Plasmidmediated quinolone resistance: a multifaceted threat. Clin. Microbiol. Rev. 22:664-689.
13. Leclercq R, Cantón R, Brown DF, Giske CG, Heisig P, Macgowan AP, Mouton JW, Nordmann P, Rodloff AC, Rossolini GM, Soussy CJ, Steinbakk M, Winstanley TG, Kahlmeter G. 21 October 2011. EUCAST expert rules in antimicrobial susceptibility testing. Clin. Microbiol. Infect. [Epub ahead of print.] doi:10.1111/j.1469-0691.2011.03703.x.
14. Ledeboer NA, Hodinka RL. 2011. Molecular detection of resistance determinants. J. Clin. Microbiol. 49:S20-S24. doi:10.1128/JCM.00771-11.
15. Niederman MS. 2009. Treatment options for nosocomial pneumonia due to MRSA. J. Infect. 59(Suppl 1):S25-S31. doi:10.1016/S0163- 4453(09)60005-0.
16. Grundmann H, Livermore DM, Giske CG, Canton R, Rossolini GM, Campos J, Vatopoulos A, Gniadkowski M, Toth A, Pfeifer Y, Jarlier V, Carmeli Y, CNSE Working Group. 2010. Carbapenem-non-susceptible Enterobacteriaceae in Europe: conclusions from a meeting of national experts. Euro Surveill. 15(46):pii_19711. http://www.eurosurveillance.org/ViewArticle.aspx?ArticleId_19711.
17. Tacconelli E. 2009. Methicillin-resistant Staphylococcus aureus: source control and surveillance organization. Clin. Microbiol. Infect. 15(Suppl 7):31-38.
18. Buynak JD. 2004. The discovery and development of modified penicillinand cephalosporin-derived beta-lactamase inhibitors. Curr. Med. Chem. 11:1951-1964.
19. Paterson DL, Bonomo RA. 2005. Extended-spectrum beta-lactamases: a clinical update. Clin. Microbiol. Rev. 18:657-686.
20. Bush K. 2010. Alarming-lactamase-mediated resistance in multidrugresistant Enterobacteriaceae. Curr. Opin. Microbiol. 13:558-564.
21. Nordmann P, Gniadkowski M, Giske CG, Poirel L, Woodford N, Miriagou V, European Network on Carbapenemases. 2012. Identification and screening of carbapenemase-producing Enterobacteriaceae. Clin. Microbiol. Infect. 18:432-438.
22. Cornaglia G, Akova M, Amicosante G, Cantón R, Cauda R, Docquier JD, Edelstein M, Frère JM, Fuzi M, Galleni M, Giamarellou H, Gniadkowski M, Koncan R, Libisch B, Luzzaro F, Miriagou V, Navarro F, Nordmann P, Pagani L, Peixe L, Poirel L, Souli M, Tacconelli E, Vatopoulos A, Rossolini GM, ESCMID Study Group for Antimicrobial Resistance Surveillance. 2007. Metallo-beta-lactamases as emerging resistance determinants in Gram-negative pathogens: open issues. Int. J. Antimicrob. Agents 29:380-388.
23. Bernabeu S, Poirel L, Nordmann P. 2012. Spectrophotometry-based detection of carbapenemase producers among Enterobacteriaceae. Diagn. Microbiol. Infect. Dis. 74:88-90.
24. Girlich D, Poirel L, Nordmann P. 2012. Value of the modified Hodge test for detection of emerging carbapenemases in Enterobacteriaceae. J. Clin. Microbiol. 50:477-479.
25. Burckhardt I, Zimmermann S. 2011. Using matrix-assisted laser desorption ionization-time of flight mass spectrometry to detect carbapenem resistance within 1 to 2.5 hours. J. Clin. Microbiol. 49:3321-3324.
26. Hrabák J, Walková R, Studentová V, Chudácková E, Bergerová T. 2011. Carbapenemase activity detection by matrix-assisted laser desorption-ionization time of flight mass spectrometry. J. Clin. Microbiol. 49:3222-3227.
27. Pan C, Xu S, Zhou H, Fu Y, Ye M, Zou H. 2007. Recent developments in methods and technology for analysis of biological samples by MALDITOF- MS. Anal. Bioanal. Chem. 387:193-204.
28. Hrabák J, Studentová V, Walková R, Zemlicková H, Jakubu V, Chudácková E, Gniadkowski M, Pfeifer Y, Perry JD, Wilkinson K, Bergerová T. 2012. Detection of NDM-1, VIM-1, KPC, OXA-48, and OXA-162 carbapenemases by matrix-assisted laser desorption ionization-time of flight mass spectrometry. J. Clin. Microbiol. 50:2441-2443.
29. Kempf M, Bakour S, Flaudrops C, Berrazeg M, Brunel JM, Drissi M, Mesli E, Touati A, Rolain JM. 2012. Rapid detection of carbapenem resistance in Acinetobacter baumannii using matrix-assisted laser desorption ionization-time of flight mass spectrometry. PLoS One 7:e31676. doi: 10.1371/journal.pone.0031676.
30. Sparbier K, Schubert S, Weller U, Boogen C, Kostrzewa M. 2012. Matrix-assisted laser desorption ionization-time of flight mass spectrometry- based functional assay for rapid detection of resistance against _-lactam antibiotics. J. Clin. Microbiol. 50:927-937.
31. Hooff GP, van Kampen JJ, Meesters RJ, van Belkum A, Goessens WH, Luider TM. 2012. Characterization of _-lactamase enzyme activity in bacterial lysates using MALDI-mass spectrometry. J. Proteome Res. 11: 79-84.
32. Bonnin RA, Naas T, Poirel L, Nordmann P. 2012. Phenotypic, biochemical, and molecular techniques for detection of metallo-_-lactamaseNDM in Acinetobacter baumannii. J. Clin. Microbiol. 50:1419-1421.
33. Kirpekar F, Douthwaite S, Roepstorff P. 2000. Mapping posttranscriptional modifications in 5S ribosomal RNA by MALDI mass spectrometry. RNA 6:296-306.
34. Kehrenberg C, Schwarz S, Jacobsen L, Hansen LH, Vester B. 2005. A new mechanism for chloramphenicol, florfenicol and clindamycin resistance: methylation of 23S ribosomal RNA at A2503. Mol. Microbiol. 57: 1064-1073.
35. Savic M, Lovric J, Tomic TI, Vasiljevic B, Conn GL. 2009. Determination of the target nucleosides for members of two families of 16S rRNA methyltransferases that confer resistance to partially overlap- ping groups of aminoglycoside antibiotics. Nucleic Acids Res. 37: 5420-5431.
36. Edwards-Jones V, Claydon MA, Evason DJ, Walker J, Fox AJ, Gordon DB. 2000. Rapid discrimination between methicillin-sensitive and methicillin- resistant Staphylococcus aureus by intact cell mass spectrometry. J. Med. Microbiol. 49:295-300.
37. Du Z, Yang R, Guo Z, Song Y, Wang J. 2002. Identification of Staphylococcus aureus and determination of its methicillin resistance by matrixassisted laser desorption/ionization time-of-flight mass spectrometry. Anal. Chem. 74:5487-5491.
38. Bernardo K, Pakulat N, Macht M, Krut O, Seifert H, Fleer S, Hünger F, Krönke M. 2002. Identification and discrimination of Staphylococcus aureus strains using matrix-assisted laser desorption/ionization-time of flight mass spectrometry. Proteomics 2:747-753.
39. Shah H, Gharbia S. 2010. Mass spectrometry for microbial proteomics. John Wiley & Sons, Inc., Chichester, United Kingdom.
40. Shah HN, Rajakaruna L, Ball G, Misra R, Al-Shahib A, Fang M, Gharbia SE. 2011. Tracing the transition of methicillin resistance in sub-populations of Staphylococcus aureus, using SELDI-TOF mass spectrometry and artificial neural network analysis. Syst. Appl. Microbiol. 34:81-86.
41. Majcherczyk PA, McKenna T, Moreillon P, Vaudaux P. 2006. The discriminatory power of MALDI-TOF mass spectrometry to differentiate between isogenic teicoplanin-susceptible and teicoplanin-resistant strains of methicillin-resistant Staphylococcus aureus. FEMS Microbiol. Lett. 255: 233-239.
42. Dubska L, Pilatova K, Dolejska M, Bortlicek Z, Frostova T, Literak I, Valik D. 2011. Surface-enhanced laser desorption ionization/timeof- flight (SELDI-TOF) mass spectrometry (MS) as a phenotypic method for rapid identification of antibiotic resistance. Anaerobe 17: 444-447.
43. Camara JE, Hays FA. 2007. Discrimination between wild-type and ampicillin- resistant Escherichia coli by matrix-assisted laser desorption/ ionization time-of-flight mass spectrometry. Anal. Bioanal. Chem. 389: 1633-1638.
44. Schaumann R, Knoop N, Genzel GH, Losensky K, Rosenkranz C, Stîngu CS, Schellenberger W, Rodloff AC, Eschrich K. 2012. A step towards the discrimination of beta-lactamase-producing clinical isolates of Enterobacteriaceae and Pseudomonas aeruginosa by MALDI-TOF mass spectrometry. Med. Sci. Monit. 18: MT71-MT77.
45. Griffin PM, Price GR, Schooneveldt JM, Schlebusch S, Tilse MH, Urbanski T, Hamilton B, Venter D. 2012. Use of matrix-assisted laser desorption ionization-time of flight mass spectrometry to identify vancomycin- resistant enterococci and investigate the epidemiology of an outbreak. J. Clin. Microbiol. 50:2918-2931.
46. Marshall T, Williams KM. 2002. Proteomics and its impact upon biomedical science. Br. J. Biomed. Sci. 59:47-64.
47. Radhouani H, Poeta P, Pinto L, Miranda J, Coelho C, Carvalho C, Rodrigues J, López M, Torres M, Vitorino R, Domingues P, Igrejas G. 2010. Proteomic characterization of vanA-containing Enterococcus recovered from seagulls at the Berlengas Natural Reserve, W Portugal. Proteome Sci. 8:48. doi:10.1186/1477-5956-8-48.
48. Al-Haroni M, Skaug N, Bakken V, Cash P. 2008. Proteomic analysis of ampicillin-resistant oral Fusobacterium nucleatum. Oral Microbiol. Immunol. 23:36-42.
49. Pinto L, Poeta P, Vieira S, Caleja C, Radhouani H, Carvalho C, Vieira-Pinto Themudo P, Torres C, Vitorino R, Domingues P, Igrejas G. 2010. Genomic and proteomic evaluation of antibiotic resistance in Salmonella strains. J. Proteomics 73:1535-1541.
50. dos Santos KV, Diniz CG, de Castro Veloso L, de Andrade HM, da Silva Giusta M, da Fonseca Pires S, Santos AV, Apolonio ACM, de Carvalho MAR, de Macedo Farias L. 2010. Proteomic analysis of Escherichia coli with experimentally induced resistance to piperacillin/tazobactam. Res. Microbiol. 161:268-275.
51. Sharma P, Kumar B, Gupta Y, Singhal N, Katoch VM, Venkatesan K, Bisht D. 2010. Proteomic analysis of streptomycin resistant and sensitive clinical isolates of Mycobacterium tuberculosis. Proteome Sci. 8:59. doi: 10.1186/1477-5956-8-59.
52. Rogers PD, Vermitsky JP, Edlind TD, Hilliard GM. 2006. Proteomic analysis of experimentally induced azole resistance in Candida glabrata. J. Antimicrob. Chemother. 58:434-438.
53. Davin-Regli A, Bolla JM, James CE, Lavigne JP, Chevalier J, Garnotel E, Molitor A, Pages JM. 2008. Membrane permeability and regulation of drug "influx and efflux" in enterobacterial pathogens. Curr. Drug Targets 9:750-759.
54. Drew D, Fröderberg L, Baars L, de Gier JW. 2003. Assembly and overexpression of membrane proteins in Escherichia coli. Biochim. Biophys. Acta 1610:3-10.
55. Gröbner S, Linke D, Schütz W, Fladerer C, Madlung J, Autenrieth IB, Witte W, Pfeifer Y. 2009. Emergence of carbapenem-non-susceptible extended-spectrum-lactamase-producing Klebsiella pneumoniae isolates at the university hospital of Tübingen, Germany. J. Med. Microbiol. 58:912-922.
56. Imperi F, Ciccosanti F, Perdomo A, Tiburzi F, Mancone C, Alonzi T, Ascenzi P, Piacentini M, Visca P, Fimia GM. 2009. Analysis of the periplasmic proteome of Pseudomonas aeruginosa, a metabolically versatile opportunistic pathogen. Proteomics 9:1901-1915.
57. Peng X, Xu C, Ren H, Lin X, Wu L, Wang S. 2005. Proteomic analysis of the sarcosine-insoluble outer membrane fraction of Pseudomonas aeruginosa responding to ampicilin, kanamycin, and tetracycline resistance. J. Proteome Res. 4:2257-2265.
58. Xu C, Lin X, Ren H, Zhang Y, Wang S, Peng X. 2006. Analysis of outer membrane proteome of Escherichia coli related to resistance to ampicillin and tetracycline. Proteomics 6:462-473.
59. Tran AX, Lester ME, Stead CM, Raetz CRH, Maskell DJ, McGrath SC, Cotter RJ, Trent MS. 2005. Resistance to the antimicrobial peptide polymyxin requires myristoylation of Escherichia coli and Salmonella typhimurium lipid A. J. Biol. Chem. 280:28186-28194.
60. Yi EC, Hackett M. 2000. Rapid isolation method for lipopolysaccharide and lipid A from Gram-negative bacteria. Analyst 125:651-656.
61. Coats SR, To TT, Jain S, Braham PH, Darveau RP. 2009. Porphyromonas gingivalis resistance to polymyxin B is determined by the lipid A 4=-phosphatase, PGN_0524. Int. J. Oral Sci. 1:126-135.
62. Beceiro A, Llobet E, Aranda J, Bengoechea JA, Doumith M, Hornsey M, Dhanji H, Chart H, Bou G, Livermore DM, Woodford N. 2011. Phosphoethanolamine modification of lipid A in colistin-resistant variants of Acinetobacter baumannii mediated by the pmrAB two-component regulatory system. Antimicrob. Agents Chemother. 55:3370-3379.
63. Cai JC, Hu YY, Zhang R, Zhou HW, Chen G-X. 2012. Detection of Ompk36 porin loss in Klebsiella spp. by matrix-assisted laser desorption ionization-time of flight mass spectrometry. J. Clin. Microbiol. 50:2179-2182.
64. Pusch W, Wurmbach J-H, Thiele H, Kostrzewa M. 2002. MALDI-TOF mass spectrometry-based SNP genotyping. Pharmacogenomics 3:537-548.
65. Stürenburg E, Storm N, Sobottka I, Horstkotte MA, Scherpe S, Aepfelbacher M, Müller S. 2006. Detection and genotyping of SHV betalactamase variants by mass spectrometry after base-specific cleavage of in vitro-generated RNA transcripts. J. Clin. Microbiol. 44:909-915.
66. Ikryannikova LN, Shitikov EA, Zhivankova DG, Il'ina EN, Edelstein MV, Govorun VM. 2008. A MALDI TOF MS-based minisequencing method for rapid detection of TEM-type extended-spectrum beta-lactamases in clinical strains of Enterobacteriaceae. J. Microbiol. Methods 75:385-391.
67. Ikryannikova LN, Afanas'ev MV, Akopian TA, Il'ina EN, Kuz'min AV, Larionova EE, Smirnova TG, Chernousova LN, Govorun VM. 2007. Massspectrometry based minisequencing method for the rapid detection of drug resistance in Mycobacterium tuberculosis. J. Microbiol. Methods 70:395-405.
68. Wang Q, Yue J, Zhang L, Xu Y, Chen J, Zhang M, Zhu B, Wang H, Wang H. 2007. A newly identified 191A/C mutation in the Rv2629 gene that was significantly associated with rifampin resistance in Mycobacterium tuberculosis. J. Proteome Res. 6:4564-4571.
69. Malakhova MV, Vereshchagin VA, Il'ina EN, Govorun VM, Zubkov MM, Priputnevich TV, Kisina VI, Kubanova AA. 2006. Analysis of genetic markers of N. gonorrhoeae resistance to beta-lactam antibiotics. Bull. Exp. Biol. Med. 141:610-615.
70. Borovskaya AD, Malakhova MV, Vereshchagin VA, Il'ina EN, Govorun VM, Priputnevich TV, Al-Hafagi N, Kubanova AA. 2007. Analysis of the contribution of molecular mechanisms into formation of gonoccocal resistance to tetracycline. Bull. Exp. Biol. Med. 144:432-437.
71. Il'ina EN, Malakhova MV, Vereshchagin VA, Govorun VM, Priputnevich TV, Kubanova AA. 2007. Direct evaluation of drug resistance parameters in gonococcus. Bull. Exp. Biol. Med. 144:227-230.
72. Malakhova MV, Vereshchagin VA, Il'ina EN, Govorun VM, Filimonova O, Grudinina SA, Sidorenko SV. 2007. MALDI-ToF mass-spectrometry in analysis of genetically determined resistance of Streptococcus pneumoniae to fluoroquinolones. Antibiot. Khimioter. 52:10-17.
73. Savinova TA, Il'ina EN, Sidorenko SV. 2010. A mass-spectrometric analysis of genetic markers of S. pneumoniae resistance to beta-lactam antibiotics. Mol. Gen. Mikrobiol. Virusol. 3:16-25.
74. Shen J, Deng DJ, Ke Y, Zhang JZ. 2008. Detection of point mutation in an in vitro-selected amoxicillin-resistant strain of Helicobacter pylori. Zhonghua Liu Xing Bing Xue Za Zhi 29:166-172.
75. Penno MAS, Ernst M, Hoffmann P. 2009. Optimal preparation methods for automated matrix-assisted laser desorption/ionization timeof- flight mass spectrometry profiling of low molecular weight proteins and peptides. Rapid Commun. Mass Spectrom. 23:2656-2662.
76. Li X, Wu X, Kim JM, Kim SS, Jin J, Li D. 2009. MALDI-TOF-MS analysis of small molecules using modified mesoporous material SBA-15 as assisted matrix. J. Am. Soc. Mass Spectrom. 20:2167-2173.
77. Lin P-C, Tseng M-C, Su A-K, Chen Y-J, Lin C-C. 2007. Functionalized magnetic nanoparticles for small-molecule isolation, identification, and quantification. Anal. Chem. 79:3401-3408.
78. Werno AM, Christner M, Anderson TP, Murdoch DR. 2012. Differentiation of Streptococcus pneumoniae from nonpneumococcal streptococci of the Streptococcus mitis group by matrix-assisted laser desorption ionization-time of flight mass spectrometry. J. Clin. Microbiol. 50:2863-2867.